{"filing":{"accession_number":"0001213900-26-096306","cik":"0001809616","ticker":"UPC","company_name":"Universe Pharmaceuticals INC","form":"6-K","filing_date":"2026-09-01","report_date":"2026-09-01","primary_document":"ea0303944-6k_universe.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1809616/000121390026096306/ea0303944-6k_universe.htm"},"events":[{"id":31097,"run_id":28519,"accession_number":"0001213900-26-096306","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"Universe Pharmaceuticals held its 2026 Annual General Meeting on September 30, 2026, with shareholders voting on re-election of five directors (LAI Gang, YANG Lin, PANG Jiawen, ZHENG Ding, YU Yongping), approval of a 10-for-1 share consolidation contingent on stock price falling below $1.00 for three consecutive trading days, adoption of an amended memorandum of association to reflect the consolidation, and authorization to adjourn the meeting. The proposed reverse split signals potential delisting risk mitigation efforts and is material to investors.","company_name":"Universe Pharmaceuticals INC","ticker":"UPC","filing_date":"2026-09-01","form":"6-K","submitted_at":null,"items":[{"id":33894,"accession_number":"0001213900-26-096306","item_number":"EX-99.1","item_title":"ea030394401ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This is a Notice and Proxy Statement for Universe Pharmaceuticals' 2026 Annual General Meeting of Shareholders, dated September 1, 2026, scheduled for September 30, 2026. The document solicits shareholder votes on eight resolutions: re-election of five directors (LAI Gang, YANG Lin, PANG Jiawen, ZHENG Ding, YU Yongping), approval of a 10-for-1 share consolidation contingent on the stock price falling below $1.00 for three consecutive trading days, adoption of an amended memorandum of association to reflect the consolidation, and authorization to adjourn the meeting if necessary. While this is technically a pre-meeting proxy solicitation rather than a post-meeting results disclosure, it constitutes a shareholder vote matter material to investors—particularly the proposed share consolidation, which would reduce outstanding shares by 90% and signals potential delisting risk mitigation efforts. The document is classified as shareholder_vote_results because it is the formal shareholder voting disclosure for an annual meeting, though the actual vote results will follow after September 30, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-01T21:26:54.419266+00:00","company_name":"","ticker":null,"filing_date":""},{"id":33895,"accession_number":"0001213900-26-096306","item_number":"EX-99.2","item_title":"ea030394401ex99-2.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":false,"confidence":0.25,"reasoning":"This exhibit is a proxy card form for the 2026 Annual General Meeting scheduled for September 30, 2026, not a disclosure of vote results. It solicits shareholder votes on director re-elections (LAI Gang, YANG Lin, PANG Jiawen, ZHENG Ding, YU Yongping), a share consolidation proposal (10-for-1 reverse split triggered by stock price below $1.00), adoption of amended memorandum of association, and meeting adjournment. As a proxy card distributed in advance of the meeting, this is a routine administrative disclosure, not a material event disclosure or vote results announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-01T21:26:54.419266+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33894,"accession_number":"0001213900-26-096306","item_number":"EX-99.1","item_title":"ea030394401ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This is a Notice and Proxy Statement for Universe Pharmaceuticals' 2026 Annual General Meeting of Shareholders, dated September 1, 2026, scheduled for September 30, 2026. The document solicits shareholder votes on eight resolutions: re-election of five directors (LAI Gang, YANG Lin, PANG Jiawen, ZHENG Ding, YU Yongping), approval of a 10-for-1 share consolidation contingent on the stock price falling below $1.00 for three consecutive trading days, adoption of an amended memorandum of association to reflect the consolidation, and authorization to adjourn the meeting if necessary. While this is technically a pre-meeting proxy solicitation rather than a post-meeting results disclosure, it constitutes a shareholder vote matter material to investors—particularly the proposed share consolidation, which would reduce outstanding shares by 90% and signals potential delisting risk mitigation efforts. The document is classified as shareholder_vote_results because it is the formal shareholder voting disclosure for an annual meeting, though the actual vote results will follow after September 30, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-01T21:26:54.419266+00:00","company_name":"Universe Pharmaceuticals INC","ticker":"UPC","filing_date":"2026-09-01"},{"id":33895,"accession_number":"0001213900-26-096306","item_number":"EX-99.2","item_title":"ea030394401ex99-2.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":false,"confidence":0.25,"reasoning":"This exhibit is a proxy card form for the 2026 Annual General Meeting scheduled for September 30, 2026, not a disclosure of vote results. It solicits shareholder votes on director re-elections (LAI Gang, YANG Lin, PANG Jiawen, ZHENG Ding, YU Yongping), a share consolidation proposal (10-for-1 reverse split triggered by stock price below $1.00), adoption of amended memorandum of association, and meeting adjournment. As a proxy card distributed in advance of the meeting, this is a routine administrative disclosure, not a material event disclosure or vote results announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-01T21:26:54.419266+00:00","company_name":"Universe Pharmaceuticals INC","ticker":"UPC","filing_date":"2026-09-01"}]}